| Literature DB >> 9190019 |
J J Tulasne1, J K Litamoi, B Morein, L Dedieu, V J Palya, M Yami, I Abusugra, D Sylla, A Bensaid.
Abstract
The control of contagious bovine pleuropneumonia (CBPP) has been clearly identified by the Organisation of African Unity/Inter-African Bureau of Animal Resources as a priority. In the first part of this article, the authors introduce the past and present vaccines, based on the two classic strains, T1, and KH3J. They describe the guidelines for vaccine production technology, and the quality control requirements for CBPP vaccines of the Office International des Epizooties. The failure of the currently used T1-SR vaccine to provoke satisfactory immunity in cattle, particularly in the newly infected areas of Africa, is pointed out. Other shortcomings of the current CBPP vaccines are also highlighted. Thus, there is a need to improve CBPP vaccines and the authors propose detailed emergency measures to address this problem. In the second part of the article, a subunit approach using immunostimulating complex technology is outlined. The authors emphasise the importance of current research in cell-mediated immunity and immunopathology, which is aimed at improving the efficacy of CBPP vaccines.Entities:
Mesh:
Substances:
Year: 1996 PMID: 9190019 DOI: 10.20506/rst.15.4.991
Source DB: PubMed Journal: Rev Sci Tech ISSN: 0253-1933 Impact factor: 1.181